What we do
FEATURED
Brexit
The ABPI is at the heart of a health sector-wide effort to establish consensus on key Brexit issues. Click here for our view and for more information about how our sector is preparing for Brexit if there's 'no deal'.

FEATURED
How medicines are priced in the UK
Medicines bring huge value to NHS patients. The development of new medicines is uncertain, costly, and involves significant rates of failure. Find out how pharmaceutical companies are pioneering R&D into the next generation of treatments.
Ethics
FEATURED
Disclosure UK
The relationship between the pharmaceutical industry and healthcare professionals (HCPs) and healthcare organisations (HCOs) plays a vital role in the development and delivery of life-enhancing and life-saving medicines.

FEATURED
Clinical trial transparency
Clinical trials are the cornerstone of the research and development process and it is through trials that pharmaceutical companies are able to demonstrate the safety and efficacy of new medicines.
Facts and Figures
FEATURED
Science and innovation
Medicines and vaccines have helped deliver incredible improvements in patient health. This section looks at expenditure on R&D in the UK and around the world.

FEATURED
Industry and academia
The UK is a world leader in medical research and innovation, built on the foundation of collaborations between industry and academia throughout Britain.
Membership and events
FEATURED
Events
Discover events for both members and non-members as well as speaking engagements of senior ABPI leadership.

FEATURED
Working with our members
As a membership organisation we work with our member companies, and the expertise of the specialists they employ, to develop and present our points of view to UK and European governments, the public and to other stakeholders.

MY ABPI LOGIN

A new ambition for cross sector collaboration with the life sciences industry to support NHS sustainability and transformation

Publication date: 19 Jun 2019

The UK Life Sciences Industrial Strategy should be required reading for every healthcare leader in the UK. It makes clear that the NHS must be an active participant with industry in delivering the shared objective of outstanding patient outcomes.

Publication size: .2 Mb

Download this document

Publications Library

Theme

Type

Guidelines

A new ambition for cross sector collaboration with the life sciences industry to support NHS sustainability and transformation

Publications Library

Theme

Type

RELATED LINKS

Devolved Nations

Quick Links

Website Info